文献速递新发突发、热带与寄生虫病

布基纳法索未产女性每周补充铁和叶酸对疟疾风险的影响:一项围受孕期双盲随机对照非劣效性试验

Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial.
PubMed 文献 · J Infect Dis · 2018-01-01

在布基纳法索农村开展的双盲随机对照非劣效性试验中,1959名未产女性被分配至每周补充60 mg铁和2.8 mg叶酸组(n=980)或仅2.8 mg叶酸组(n=979),直至首次产前检查或未妊娠满18个月。结果显示两组在首次产前检查时疟原虫血症率、贫血、缺铁及血浆铁生物标志物均无差异,未妊娠女性中同样无差异。结论认为每周补铁未增加疟疾风险,也未改善铁状态或减少贫血。

要点

  • 每周补铁未增加未产女性疟疾风险。
  • 每周补铁未改善铁状态或减少贫血。
  • 世界卫生组织普遍补充指南可能需重新评估。

核心结论

  • 每周补充铁未增加疟疾风险,未改善铁状态,也未减少贫血,在年轻、多为青春期月经期女性及早期妊娠中均如此。
  • 世界卫生组织关于年轻未产女性普遍补充的指南可能需要重新评估。

研究设计与样本

  • 围受孕期、双盲、随机对照非劣效性试验,在布基纳法索农村开展。
  • 共1959名未产女性被分配至每周补充60 mg铁和2.8 mg叶酸组(n=980)或2.8 mg叶酸组(n=979),直至首次产前检查(ANC1),若仍未妊娠则至18个月。
  • 315名女性参加了ANC1,916名保持未妊娠。

主要发现

  • 在ANC1时,疟原虫血症率:铁组53.4%(95%CI 45.7%-61.0%)vs 对照组55.3%(95%CI 47.3%-62.9%),患病率比0.97(95%CI 0.79-1.18),P=0.82。
  • 在ANC1时,贫血调整效应0.96(95%CI 0.83-1.10),P=0.52;缺铁调整风险比(aRR)0.84(95%CI 0.46-1.54),P=0.58;血浆铁生物标志物无差异。
  • 在未妊娠女性中,疟原虫血症率:铁组42.9%(95%CI 38.3%-47.5%)vs 对照组39.2%(95%CI 34.9%-43.7%),患病率比1.09(95%CI 0.93-1.28),P=0.282;贫血aRR 0.90(95%CI 0.78-1.05),P=0.17;缺铁aRR 0.99(95%CI 0.77-1.28),P=0.96;铁生物标志物无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The safety of iron supplementation for young women is uncertain in malaria-endemic settings. METHODS: This was a double-blind, randomized controlled noninferiority trial in rural Burkina Faso. RESULTS: A total of 1959 nulliparae were assigned to weekly supplementation (60 mg iron and 2.8 mg folic acid) (n = 980) or 2.8 mg folic acid (n = 979) until first antenatal visit (ANC1), or 18 months if remaining nonpregnant. Three hundred fifteen women attended ANC1, and 916 remained nonpregnant. There was no difference at ANC1 in parasitemia prevalence (iron, 53.4% [95% confidence interval {CI}, 45.7%-61.0%]; control, 55.3% [95% CI, 47.3%-62.9%]; prevalence ratio, 0.97 [95% CI, .79-1.18]; P = .82), anemia (adjusted effect, 0.96 [95% CI, .83-1.10]; P = .52), iron deficiency (adjusted risk ratio [aRR], 0.84 [95% CI, .46-1.54]; P = .58), or plasma iron biomarkers. Outcomes in nonpregnant women were parasitemia (iron, 42.9% [95% CI, 38.3%-47.5%]; control, 39.2% [95% CI, 34.9%-43.7%]; prevalence ratio, 1.09 [95% CI, .93-1.28]; P = .282); anemia (aRR, 0.90 [95% CI, .78-1.05]; P = .17), and iron deficiency (aRR, 0.99 [95% CI, .77-1.28]; P = .96), with no iron biomarker differences. CONCLUSIONS: Weekly iron supplementation did not increase malaria risk, improve iron status, or reduce anemia in young, mostly adolescent menstruating women, nor in early pregnancy. World Health Organization Guidelines for universal supplementation for young nulliparous women may need reassessment. CLINICAL TRIALS REGISTRATION: NCT01210040.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Gies S, Diallo S, Roberts SA, et al. Effects of Weekly Iron and Folic Acid Supplements on Malaria Risk in Nulliparous Women in Burkina Faso: A Periconceptional, Double-Blind, Randomized Controlled Noninferiority Trial. J Infect Dis. 2018. PMID: 29733403. doi:10.1093/infdis/jiy257

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。